Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
LA JOLLA PHARMACEUTICAL CO (LJPC)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/24/2022 |
4
| Rosen Robert (Director) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Disposed/sold 18,000 options to buy
@ $8.52, valued at
$153.4k
Disposed/sold 10,000 options to buy
@ $19.69, valued at
$196.9k
Disposed/sold 10,000 options to buy
@ $28.24, valued at
$282.4k
Disposed/sold 10,000 options to buy
@ $19.19, valued at
$191.9k
Disposed/sold 10,000 options to buy
@ $28.1, valued at
$281k
Disposed/sold 12,000 options to buy
@ $5.99, valued at
$71.9k
Disposed/sold 12,000 options to buy
@ $3.93, valued at
$47.2k
Disposed/sold 30,000 options to buy
@ $4.53, valued at
$135.9k
Disposed/sold 30,000 options to buy
@ $4.81, valued at
$144.3k
|
|
| 08/24/2022 |
4
| RAMSAY DAVID A (Director) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Disposed/sold 100,000 shares
@ $6.23, valued at
$623k
Disposed/sold 18,000 options to buy
@ $8.43, valued at
$151.7k
Disposed/sold 12,000 options to buy
@ $3.93, valued at
$47.2k
Disposed/sold 30,000 options to buy
@ $4.53, valued at
$135.9k
Disposed/sold 30,000 options to buy
@ $4.81, valued at
$144.3k
|
|
| 08/24/2022 |
4
| TANG KEVIN C (10% Owner) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Unknown transaction of 9,607,934 shares
@ $6.23, valued at
$59.9M
Disposed/sold 18,000 options to buy
@ $9.2, valued at
$165.6k
Disposed/sold 10,000 options to buy
@ $19.69, valued at
$196.9k
Disposed/sold 10,000 options to buy
@ $28.24, valued at
$282.4k
Disposed/sold 10,000 options to buy
@ $19.19, valued at
$191.9k
Disposed/sold 10,000 options to buy
@ $28.1, valued at
$281k
Disposed/sold 12,000 options to buy
@ $5.99, valued at
$71.9k
Disposed/sold 12,000 options to buy
@ $3.93, valued at
$47.2k
Disposed/sold 30,000 options to buy
@ $4.53, valued at
$135.9k
Disposed/sold 30,000 options to buy
@ $4.81, valued at
$144.3k
Unknown transaction of 3,519 options to buy
@ $0 |
|
| 08/24/2022 |
4
| Edwards Larry G. (CEO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Disposed/sold 11,969 shares
@ $6.23, valued at
$74.6k
Disposed/sold 400,000 options to buy
@ $3.89, valued at
$1.6M
Disposed/sold 278,350 options to buy
@ $4.53, valued at
$1.3M
Disposed/sold 322 options to buy
@ $4.18, valued at
$1.3k
Disposed/sold 304 options to buy
@ $4.44, valued at
$1.3k
Disposed/sold 358 options to buy
@ $3.76, valued at
$1.3k
Disposed/sold 314 options to buy
@ $4.3, valued at
$1.4k
Disposed/sold 275 options to buy
@ $4.9, valued at
$1.3k
Disposed/sold 315 options to buy
@ $4.28, valued at
$1.3k
Disposed/sold 374 options to buy
@ $3.61, valued at
$1.4k
Disposed/sold 338 options to buy
@ $3.98, valued at
$1.3k
|
|
| 08/24/2022 |
4
| Hearne Michael S (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Disposed/sold 1,675 options to buy
@ $4.63, valued at
$7.8k
Disposed/sold 169 options to buy
@ $4.46, valued at
$753.7
Disposed/sold 185 options to buy
@ $4.09, valued at
$756.7
Disposed/sold 177 options to buy
@ $4.27, valued at
$755.8
Disposed/sold 173 options to buy
@ $4.37, valued at
$756
Disposed/sold 185 options to buy
@ $4.08, valued at
$754.8
Disposed/sold 236 options to buy
@ $3.2, valued at
$755.2
Disposed/sold 236 options to buy
@ $3.19, valued at
$752.8
Unknown transaction of 3,519 options to buy
@ $0 |
|
| 08/24/2022 |
4
| Johnson Laura L. (Director) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Disposed/sold 500 shares
@ $6.23, valued at
$3.1k
Disposed/sold 13,500 options to buy
@ $6, valued at
$81k
Disposed/sold 13,000 options to buy
@ $10.84, valued at
$140.9k
Disposed/sold 10,000 options to buy
@ $19.69, valued at
$196.9k
Disposed/sold 10,000 options to buy
@ $28.24, valued at
$282.4k
Disposed/sold 10,000 options to buy
@ $19.19, valued at
$191.9k
Disposed/sold 10,000 options to buy
@ $28.1, valued at
$281k
Disposed/sold 12,000 options to buy
@ $5.99, valued at
$71.9k
Disposed/sold 12,000 options to buy
@ $3.93, valued at
$47.2k
Disposed/sold 30,000 options to buy
@ $4.53, valued at
$135.9k
Disposed/sold 30,000 options to buy
@ $4.81, valued at
$144.3k
|
|
| 08/24/2022 |
4
| Johnson Craig A (Director) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Disposed/sold 12,000 shares
@ $6.23, valued at
$74.8k
Disposed/sold 18,000 options to buy
@ $6, valued at
$108k
Disposed/sold 19,000 options to buy
@ $10.84, valued at
$206k
Disposed/sold 10,000 options to buy
@ $19.69, valued at
$196.9k
Disposed/sold 10,000 options to buy
@ $28.24, valued at
$282.4k
Disposed/sold 10,000 options to buy
@ $19.19, valued at
$191.9k
Disposed/sold 10,000 options to buy
@ $28.1, valued at
$281k
Disposed/sold 12,000 options to buy
@ $5.99, valued at
$71.9k
Disposed/sold 30,000 options to buy
@ $5.25, valued at
$157.5k
Disposed/sold 30,000 options to buy
@ $4.53, valued at
$135.9k
Disposed/sold 30,000 options to buy
@ $4.81, valued at
$144.3k
|
|
| 08/24/2022 |
4
| Hearne Michael S (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Disposed/sold 10,186 shares
@ $6.23, valued at
$63.5k
Unknown transaction of 9,607,934 shares
@ $6.23, valued at
$59.9M
Disposed/sold 100,000 options to buy
@ $4.55, valued at
$455k
Disposed/sold 169 options to buy
@ $3.91, valued at
$660.8
Disposed/sold 196 options to buy
@ $3.4, valued at
$666.4
Disposed/sold 141 options to buy
@ $4.68, valued at
$659.9
Disposed/sold 134 options to buy
@ $4.97, valued at
$666
Disposed/sold 52,191 options to buy
@ $4.53, valued at
$236.4k
Disposed/sold 147 options to buy
@ $4.5, valued at
$661.5
Disposed/sold 1,648 options to buy
@ $3.88, valued at
$6.4k
Disposed/sold 136 options to buy
@ $5.35, valued at
$727.6 |
|
| 08/24/2022 |
4
| TANG KEVIN C (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Unknown transaction of 9,607,934 shares
@ $6.23, valued at
$59.9M
Unknown transaction of 3,519 options to buy
@ $0 |
|
| 07/12/2022 |
4
| Johnson Craig A (Director) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Exercised 12,000 options to buy
@ $3.93, valued at
$47.2k
|
|
| 07/05/2022 |
4
| Hearne Michael S (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 236 shares
@ $2.7115, valued at
$639.9
Granted 236 options to buy
@ $3.19, valued at
$752.8 |
|
| 06/17/2022 |
4
| Hearne Michael S (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 236 shares
@ $2.72, valued at
$641.9
Granted 236 options to buy
@ $3.2, valued at
$755.2 |
|
| 06/02/2022 |
4
| Hearne Michael S (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 189 shares
@ $3.4085, valued at
$644.2
Granted 189 options to buy
@ $4.01, valued at
$757.9 |
|
| 05/17/2022 |
4
| Hearne Michael S (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 188 shares
@ $3.4085, valued at
$640.8
Granted 188 options to buy
@ $4.01, valued at
$753.9 |
|
| 05/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/18/2022 |
4
| Edwards Larry G. (CEO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 296 shares
@ $3.7145, valued at
$1.1k
Granted 296 options to buy
@ $4.37, valued at
$1.3k
|
|
| 04/18/2022 |
4
| Hearne Michael S (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 173 shares
@ $3.7145, valued at
$642.6
Granted 173 options to buy
@ $4.37, valued at
$756 |
|
| 04/04/2022 |
4
| Edwards Larry G. (CEO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 334 shares
@ $3.6295, valued at
$1.2k
Granted 334 options to buy
@ $4.27, valued at
$1.4k
|
|
| 04/04/2022 |
4
| Hearne Michael S (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 177 shares
@ $3.6295, valued at
$642.4
Granted 177 options to buy
@ $4.27, valued at
$755.8 |
|
| 03/17/2022 |
4
| Edwards Larry G. (CEO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 361 shares
@ $3.366, valued at
$1.2k
Granted 361 options to buy
@ $3.96, valued at
$1.4k
|
|
| 03/17/2022 |
4
| Hearne Michael S (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 190 shares
@ $3.366, valued at
$639.5
Granted 190 options to buy
@ $3.96, valued at
$752.4 |
|
| 03/02/2022 |
4
| Edwards Larry G. (CEO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 350 shares
@ $3.4765, valued at
$1.2k
Granted 350 options to buy
@ $4.09, valued at
$1.4k
|
|
| 03/02/2022 |
4
| Hearne Michael S (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 185 shares
@ $3.4765, valued at
$643.2
Granted 185 options to buy
@ $4.09, valued at
$756.7 |
|
| 02/17/2022 |
4
| Edwards Larry G. (CEO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 320 shares
@ $3.791, valued at
$1.2k
Granted 320 options to buy
@ $4.46, valued at
$1.4k
|
|
| 02/17/2022 |
4
| Hearne Michael S (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 169 shares
@ $3.791, valued at
$640.7
Granted 169 options to buy
@ $4.46, valued at
$753.7 |
|
| 02/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/19/2022 |
4
| Edwards Larry G. (CEO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 273 shares
@ $4.182, valued at
$1.1k
Granted 273 options to buy
@ $4.92, valued at
$1.3k
|
|
| 01/19/2022 |
4
| Hearne Michael S (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 148 shares
@ $4.182, valued at
$618.9
Granted 148 options to buy
@ $4.92, valued at
$728.2 |
|
| 01/14/2022 |
4
| Rosen Robert (Director) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 30,000 options to buy
@ $4.81, valued at
$144.3k
|
|
| 01/14/2022 |
4
| RAMSAY DAVID A (Director) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 30,000 options to buy
@ $4.81, valued at
$144.3k
|
|
| 01/14/2022 |
4
| Johnson Craig A (Director) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 30,000 options to buy
@ $4.81, valued at
$144.3k
|
|
| 01/14/2022 |
4
| Johnson Laura L. (Director) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 30,000 options to buy
@ $4.81, valued at
$144.3k
|
|
| 01/14/2022 |
4
| Edwards Larry G. (CEO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 418,944 options to buy
@ $4.81, valued at
$2M
|
|
|
|
|